363 related articles for article (PubMed ID: 29874641)
1. Adenomyosis and Endometrial Cancer: Literature Review.
Habiba M; Pluchino N; Petignat P; Bianchi P; Brosens IA; Benagiano G
Gynecol Obstet Invest; 2018; 83(4):313-328. PubMed ID: 29874641
[TBL] [Abstract][Full Text] [Related]
2. Serous carcinoma arising from uterine adenomyosis/adenomyotic cyst of the cervical stump: a report of 3 cases.
Lu B; Chen Q; Zhang X; Cheng L
Diagn Pathol; 2016 Jun; 11(1):46. PubMed ID: 27260518
[TBL] [Abstract][Full Text] [Related]
3. [Clinical analysis of 30 patients with atypical glandular hyperplasia or malignant transformation in foci of adenomyosis].
Liu YT; Wang S; Shi HH; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2020 Jul; 55(7):471-475. PubMed ID: 32842251
[No Abstract] [Full Text] [Related]
4. Corroborating evidence for platelet-induced epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis.
Liu X; Shen M; Qi Q; Zhang H; Guo SW
Hum Reprod; 2016 Apr; 31(4):734-49. PubMed ID: 26908845
[TBL] [Abstract][Full Text] [Related]
5. Adenomyosis As a Confounder to Accurate Endometrial Cancer Staging.
Khalifa MA; Atri M; Klein ME; Ghatak S; Murugan P
Semin Ultrasound CT MR; 2019 Aug; 40(4):358-363. PubMed ID: 31375175
[TBL] [Abstract][Full Text] [Related]
6. Adenomyosis as a Risk Factor for Myometrial or Endometrial Neoplasms-Review.
Szubert M; Kozirog E; Wilczynski J
Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206475
[TBL] [Abstract][Full Text] [Related]
7. Immunocytochemical analysis of proliferative activity of endometrial and myometrial cell populations in focal and stromal adenomyosis.
Nepomnyashchikh LM; Lushnikova EL; Molodykh OP; Pichigina AK
Bull Exp Biol Med; 2013 Aug; 155(4):512-7. PubMed ID: 24143380
[TBL] [Abstract][Full Text] [Related]
8. Significance of adenomyosis on tumor progression and survival outcome of endometrial cancer.
Matsuo K; Cahoon SS; Gualtieri M; Scannell CA; Jung CE; Takano T; Paulson RJ; Muderspach LI; Roman LD
Ann Surg Oncol; 2014 Dec; 21(13):4246-55. PubMed ID: 25001096
[TBL] [Abstract][Full Text] [Related]
9. Grade 2 endometrioid adenocarcinoma arising from adenomyosis of the uterus: report of a case.
Kazandi M; Zeybek B; Terek MC; Zekioglu O; Ozdemir N; Oztekin K
Eur J Gynaecol Oncol; 2010; 31(6):719-21. PubMed ID: 21319528
[TBL] [Abstract][Full Text] [Related]
10. Structural and molecular features of the endomyometrium in endometriosis and adenomyosis.
Benagiano G; Brosens I; Habiba M
Hum Reprod Update; 2014; 20(3):386-402. PubMed ID: 24140719
[TBL] [Abstract][Full Text] [Related]
11. Malignant changes in adenomyosis in patients with endometrial adenocarcinoma: A case series.
Mao X; Zheng W; Mao W
Medicine (Baltimore); 2017 Oct; 96(43):e8336. PubMed ID: 29069006
[TBL] [Abstract][Full Text] [Related]
12. The expression and functionality of stromal caveolin 1 in human adenomyosis.
Zhao L; Zhou S; Zou L; Zhao X
Hum Reprod; 2013 May; 28(5):1324-38. PubMed ID: 23442759
[TBL] [Abstract][Full Text] [Related]
13. Malignant changes in adenomyosis in patients with endometrioid adenocarcinoma.
Kucera E; Hejda V; Dankovcik R; Valha P; Dudas M; Feyereisl J
Eur J Gynaecol Oncol; 2011; 32(2):182-4. PubMed ID: 21614909
[TBL] [Abstract][Full Text] [Related]
14. Oestrogen-induced epithelial-mesenchymal transition of endometrial epithelial cells contributes to the development of adenomyosis.
Chen YJ; Li HY; Huang CH; Twu NF; Yen MS; Wang PH; Chou TY; Liu YN; Chao KC; Yang MH
J Pathol; 2010 Nov; 222(3):261-70. PubMed ID: 20814901
[TBL] [Abstract][Full Text] [Related]
15. Pathology and Pathogenesis of Adenomyosis.
Antero MF; Ayhan A; Segars J; Shih IM
Semin Reprod Med; 2020 May; 38(2-03):108-118. PubMed ID: 33080632
[TBL] [Abstract][Full Text] [Related]
16. Characterising the immune cell phenotype of ectopic adenomyosis lesions compared with eutopic endometrium: A systematic review.
Maclean A; Barzilova V; Patel S; Bates F; Hapangama DK
J Reprod Immunol; 2023 Jun; 157():103925. PubMed ID: 36870297
[TBL] [Abstract][Full Text] [Related]
17. The role of CD10 staining in distinguishing invasive endometrial adenocarcinoma from adenocarcinoma involving adenomyosis.
Nascimento AF; Hirsch MS; Cviko A; Quade BJ; Nucci MR
Mod Pathol; 2003 Jan; 16(1):22-7. PubMed ID: 12527709
[TBL] [Abstract][Full Text] [Related]
18. Good outcome of endometrial cancer patients coexisting with adenomyosis is a result of their associated favorable clinico-pathological parameters.
Chou FW; Lee NR; Wang PH
Taiwan J Obstet Gynecol; 2023 Nov; 62(6):795-796. PubMed ID: 38008494
[No Abstract] [Full Text] [Related]
19. Immunological changes associated with adenomyosis: a systematic review.
Bourdon M; Santulli P; Jeljeli M; Vannuccini S; Marcellin L; Doridot L; Petraglia F; Batteux F; Chapron C
Hum Reprod Update; 2021 Jan; 27(1):108-129. PubMed ID: 33099635
[TBL] [Abstract][Full Text] [Related]
20. [Expression and significance of bcl-2, bax and ER in foci of adenomyosis].
Li B; Wang L; Fan Y; Wang J; Guo D
Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):923-7. PubMed ID: 23324193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
